Florian Bassermann - Concepedia

Author

Florian Bassermann

Also Known As

Alex A. Adjei, Bassermann, Florian, F Bassermann, F. Bassermann, FLORIAN BASSERMANN, Florian Bassermann, Florian C. Bassermann, Helmut Ostermann, J Slotta-Huspenina

246

Publications

Citations

H-Index

Concepts

All Affiliations

Technical University of Munich Klinikum rechts der Isar German Cancer Research Center Heidelberg University Ludwig-Maximilians-Universität München

About

Florian Bassermann is an author at Technical University of Munich specializing in medicine, cell biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	28	3.2K
2	Cell Biology	18	19	2.7K
3	Health Sciences	5	5	92
4	Natural Sciences	5	5	879
5	Biochemistry	3	3	149

Florian Bassermann

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
The target landscape of clinical kinase drugs Susan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm, Science Tumor BiologyProteomicsdb DatabaseDrug TargetOncologyTarget Landscape	2017	845
SCF <sup>Fbxl3</sup> Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins Luca Busino, Florian Bassermann, Alessio Maiolica, Science Molecular RegulationMolecular BiologyCryptochromeCircadian ClockCell Cycle	2007	494
The Cdc14B-Cdh1-Plk1 Axis Controls the G2 DNA-Damage-Response Checkpoint Florian Bassermann, David Frescas, Daniele Guardavaccaro, Cell Genome InstabilityCdc14b-cdh1-plk1 Axis ControlsCell DivisionCell RegulationDna Replication	2008	398
JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes David Frescas, Daniele Guardavaccaro, Florian Bassermann, Nature ChromatinTranscriptional RegulationNatural SciencesGeneticsRna Biology	2007	279
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study Ö. Türeci, Uğur Şahin, Henning Schulze‐Bergkamen, Annals of Oncology	2019	232
βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis Elinor Dehan, Florian Bassermann, Daniele Guardavaccaro, Molecular Cell Bimel Inhibits ApoptosisMedicineApoptosisCell DeathCell Biology	2009	192
Immunomodulatory drugs disrupt the cereblon–CD147–MCT1 axis to exert antitumor activity and teratogenicity Ruth Eichner, Michael Heider, Vanesa Fernández‐Sáiz, Nature Medicine Cancer ImmunosurveillanceOncologyAntitumor ActivityMedicineImmunology	2016	180
RIG-I activation is critical for responsiveness to checkpoint blockade Simon Heidegger, Alexander Wintges, Florian Stritzke, Science Immunology	2019	128
SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma Vanesa Fernández‐Sáiz, Bianca‐Sabrina Targosz, Simone Lemeer, Nature Cell Biology Hematological MalignancyGrowth Factor WithdrawalMedicineMultiple MyelomaCancer Biology	2012	117
Prognostic Implications of the Seventh Edition of the International Union Against Cancer Classification for Patients With Gastric Cancer: The Western Experience of Patients Treated in a Single-Center European Institution Daniel Reim, Martin Loos, Fabian Vogl, Journal of Clinical Oncology	2012	114

Page 1